Clinical Trials Related to Diffuse Large B Cell Lymphoma

Related studies linked through entity extraction aliases.

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Status: TERMINATED
Phase: PHASE2

TREatment of degeNerative and Neoplastic Diseases With Rituximab

Status: UNKNOWN
Phase: PHASE2/PHASE3

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

Status: COMPLETED
Phase: PHASE1/PHASE2

A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)

Status: COMPLETED
Phase: PHASE2

Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma

Status: TERMINATED
Phase: N/A

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

Status: COMPLETED
Phase: NA

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Status: COMPLETED
Phase: PHASE4

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Status: UNKNOWN
Phase: PHASE2